Thus, the assay introduced in this study is a nonradioactive receptor binding method that shows promise as a high throughput screening method for large-scale testing of environmental and industrial chemicals for ER binding interactions.
The second level is a set of molecular binding prediction methods that are used to compute the binding affinity of the molecules represented in the agent-based model.
Therefore, it is desirable to develop binding prediction methods that do not rely on the availability of peptide:MHC binding data.
Third, presumably due to the importance of non-linear interactions between amino acid positions in defining DNA-binding specificity, methods that can capture interactions and non-linearities have a clear advantage: there is almost always at least one variant of each non-linear method, i.e. NN, RF and SVM_R, that outperforms every linear method we employed.
Figure 2 compares the energy band structure of the modelled armchair-edge graphene nanoribbon obtained from the first nearest-neighbour tight binding method with that obtained by including up to third nearest-neighbours.
A case study of experimental and statistical approaches for cross-validating and examining the equivalence of two ligand binding assay (LBA) methods that were employed in pharmacokinetic (PK) studies is presented.
However, because the base composition of promoters in higher eukaryotes is highly variable (Sinha et al., 2008), binding affinity scoring methods that ignore this variability might predict TF GO term associations that are not biologically meaningful.
Here, we analyze protein ligand complexes and discuss methods that assist binding site identification, prediction of druggability and binding site comparison.
When the DNA binding domain is novel, methods that do not rely directly on previous data may be advantageous.
DOI: http://dx.doi.org/10.7554/eLife.02758.018 To test this hypothetical mechanism, we developed a 'diffusion-binding' model ('Materials and methods') that was constrained by experimentally-determined parameters (Table 2) to best reflect the in vivo situation.
